Prediction of breast cancer sensitivity to neoadjuvant chemotherapy based on status of DNA damage repair proteins

Abstract

IntroductionVarious agents used in breast cancer chemotherapy provoke DNA double-strand breaks (DSBs). DSB repair competence determines the sensitivity of cells to these agents whereby aberrations in the repair machinery leads to apoptosis. Proteins required for this pathway can be detected as nuclear foci at sites of DNA damage when the pathway is intact. Here we investigate whether focus formation of repair proteins can predict chemosensitivity of breast cancer.MethodsCore needle biopsy specimens were obtained from sixty cases of primary breast cancer before and 18-24 hours after the first cycle of neoadjuvant epirubicin plus cyclophosphamide (EC) treatment. Nuclear focus formation of DNA damage repair proteins was immunohistochemically analyzed and compared with tumor response to chemotherapy.ResultsEC treatment induced nuclear foci of γH2AX, conjugated ubiquitin, and Rad51 in a substantial amount of cases. In contrast, BRCA1 foci were observed before treatment in the majority of the cases and only decreased after EC in thirteen cases. The presence of BRCA1-, γH2AX-, or Rad51-foci before treatment or the presence of Rad51-foci after treatment was inversely correlated with tumor response to chemotherapy. DNA damage response (DDR) competence was further evaluated by considering all four repair indicators together. A high DDR score significantly correlated with low tumor response to EC and EC + docetaxel whereas other clinicopathological factors analyzed did not.ConclusionsHigh performing DDR focus formation resulted in tumor resistance to DNA damage-inducing chemotherapy. Our results suggested an importance of evaluation of DDR competence to predict breast cancer chemosensitivity, and merits further studying into its usefulness in exclusion of non-responder patients.

gamma-H2AX: Can it be established as a classical cancer prognostic factor?

“…However, the diversity of this cell population makes the assessment of gH2AX in nonsynchronized populations problematic. 41,42 Skin and plucked cells are also easily collectable. 43 Buccal cells are easily collected and may offer a sensitive index for low-dose radiation exposure.…”

Bcl-2 Inhibits Nuclear Homologous Recombination by Localizing BRCA1 to the Endomembranes

“…In response to DNA damage, BRCA1 assembles into nuclear foci, and these structures appear to be a prerequisite for efficient HR. Monitoring the formation of BRCA1 foci is frequently used to estimate DNA repair/recombination in different situations, including in tumor cells (21)(22)(23)(24)(25)(26). Because Bcl-2 impacts HR, we investigated the effects of Bcl-2 on the formation of endogenous BRCA1 foci induced by ionizing radiation (IR).…”

Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)

“…ERCC1 has been associated with the response to cisplatin of several tumours, including CCA 298 . RAD51, upregulated in most CCA 299 , is a recombinase involved in repairing DNA double-strand breaks and is associated with poor sensitivity to cyclophosphamide, epirubicin and docetaxel 300 . The DNA mismatch repair system recognizes and repairs erroneous insertion of nucleotides as well as short insertions and deletions.…”